Wall Street Zen upgraded shares of Callan JMB (NASDAQ:CJMB – Free Report) to a hold rating in a research report report published on Saturday morning,Wall Street Zen reports.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Callan JMB in a report on Friday, July 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
View Our Latest Analysis on CJMB
Callan JMB Stock Performance
Callan JMB (NASDAQ:CJMB – Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.22) EPS for the quarter. The firm had revenue of $1.38 million for the quarter. Callan JMB had a negative return on equity of 444.84% and a negative net margin of 191.96%.
Institutional Inflows and Outflows
A hedge fund recently bought a new position in Callan JMB stock. Bard Associates Inc. bought a new position in Callan JMB Inc. (NASDAQ:CJMB – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 229,250 shares of the company’s stock, valued at approximately $184,000. Bard Associates Inc. owned 4.05% of Callan JMB at the end of the most recent reporting period.
About Callan JMB
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.
Read More
- Five stocks we like better than Callan JMB
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.
